<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02708004</url>
  </required_header>
  <id_info>
    <org_study_id>AC-080-102</org_study_id>
    <nct_id>NCT02708004</nct_id>
  </id_info>
  <brief_title>Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects</brief_title>
  <official_title>A Single-center, Double-blind, Randomized, Placebo-controlled, Two-way Crossover Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Actelion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study will be conducted to evaluate the effect of ACT-132577 on fluid
      homeostasis in healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 1, 2016</start_date>
  <completion_date type="Actual">December 1, 2016</completion_date>
  <primary_completion_date type="Actual">December 1, 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>from Day 1 to Day 9</time_frame>
    <description>Change from baseline</description>
  </primary_outcome>
  <other_outcome>
    <measure>Treatment-emergent Adverse Events</measure>
    <time_frame>From Day 1 up to End-of-Study (i.e. for at least 25 days)</time_frame>
    <description>Number of subjects with Adverse Events</description>
  </other_outcome>
  <other_outcome>
    <measure>Treatment-emergent Serious Adverse Events</measure>
    <time_frame>From Screening (Day -3) up to Follow-up (i.e. for at least 49 days)</time_frame>
    <description>Number of subjects with Serious Adverse Events</description>
  </other_outcome>
  <other_outcome>
    <measure>Glomerular filtration rate (GFR)</measure>
    <time_frame>At 0 h of Day 1, at 1 h, 2 h, 4 h, 6 h and 10 h of Day 1 &amp; Day 9</time_frame>
    <description>Change from baseline to each scheduled timepoint</description>
  </other_outcome>
  <other_outcome>
    <measure>Fractional sodium excretion in 24 h urine samples [mmol per day]</measure>
    <time_frame>At 0 h of Day 1, at 1 h, 2 h, 4 h, 6 h and 10 h of Day 1 &amp; Day 9</time_frame>
    <description>Fractional excretion will be calculated as the clearance of sodium divided by the clearance of creatinine. Change from baseline to each scheduled timepoint</description>
  </other_outcome>
  <other_outcome>
    <measure>Fractional lithium excretion in 24 h urine samples [mmol per day]</measure>
    <time_frame>At 0 h of Day 1, at 1 h, 2 h, 4 h, 6 h and 10 h of Day 1 &amp; Day 9</time_frame>
    <description>Fractional excretion will be calculated as the clearance of lithium divided by the clearance of creatinine. Change from baseline to each scheduled timepoint</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>ACT-132577</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 different dose levels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching active drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ACT-132577</intervention_name>
    <description>Formulated in capsules in 2 different strengths; 2 capsules per day</description>
    <arm_group_label>ACT-132577</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching active drug</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Healthy on the basis of medical history, physical examination, cardiovascular
             assessments and hematology, clinical chemistry, and urinalysis tests

          -  Body mass index between 20.0 and 25.0 kg/m2 (inclusive) at screening

        Exclusion Criteria:

        - Any circumstances or conditions, which, in the opinion of the investigator, may affect
        full participation in the study or compliance with the protocol
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Investigator Site Lausanne</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2016</study_first_submitted>
  <study_first_submitted_qc>March 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2016</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

